RYCEX Rydex Europe 1.25x Strategy C Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).

The investment seeks to provide investment results that correlate, before fees and expenses, to the performance of 125% of the fair value of the STOXX Europe 50® Index. The fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The index is a capitalization-weighted index composed of 50 European blue-chip stocks consisting of capitalizations ranging from $4.1 million to $644. The fund is non-diversified.

The average market capitalization across the Rydex Europe 1.25x Strategy C MF is 316.55B. The market cap for tickers in the group ranges from 197.93B to 486.73B. NVO holds the highest valuation in this group at 486.73B. The lowest valued company is NVS at 197.93B.

The average weekly volume growth across all stocks in the Rydex Europe 1.25x Strategy C MF was 25%. For the same stocks of the MF, the average monthly volume growth was -23% and the average quarterly volume growth was 36%